nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluorouracil—Nucleic Acid Synthesis Inhibitors—Gemcitabine—lung cancer	0.326	1	CiPCiCtD
Fluorouracil—colon cancer—lung cancer	0.201	1	CtDrD
Fluorouracil—ABCC3—lung cancer	0.0561	0.329	CbGaD
Fluorouracil—TYMS—lung cancer	0.0448	0.263	CbGaD
Fluorouracil—SLC29A1—Pemetrexed—lung cancer	0.0389	0.198	CbGbCtD
Fluorouracil—TYMS—Pemetrexed—lung cancer	0.0361	0.184	CbGbCtD
Fluorouracil—CYP2A6—lung cancer	0.0305	0.179	CbGaD
Fluorouracil—ABCG2—lung cancer	0.0273	0.16	CbGaD
Fluorouracil—SLC29A1—Gemcitabine—lung cancer	0.014	0.0714	CbGbCtD
Fluorouracil—TYMS—Gemcitabine—lung cancer	0.013	0.0661	CbGbCtD
Fluorouracil—ALB—lung cancer	0.0119	0.0697	CbGaD
Fluorouracil—ABCC5—Cisplatin—lung cancer	0.00778	0.0396	CbGbCtD
Fluorouracil—MTHFR—Methotrexate—lung cancer	0.00719	0.0366	CbGbCtD
Fluorouracil—TYMS—Methotrexate—lung cancer	0.00612	0.0312	CbGbCtD
Fluorouracil—ABCG2—Topotecan—lung cancer	0.00505	0.0257	CbGbCtD
Fluorouracil—ABCC3—Cisplatin—lung cancer	0.00489	0.0249	CbGbCtD
Fluorouracil—ABCC3—Etoposide—lung cancer	0.00481	0.0245	CbGbCtD
Fluorouracil—ABCG2—Gefitinib—lung cancer	0.00462	0.0235	CbGbCtD
Fluorouracil—ABCG2—Teniposide—lung cancer	0.00448	0.0228	CbGbCtD
Fluorouracil—SLC22A7—Docetaxel—lung cancer	0.00344	0.0175	CbGbCtD
Fluorouracil—ABCC3—Doxorubicin—lung cancer	0.00328	0.0167	CbGbCtD
Fluorouracil—ALB—Gefitinib—lung cancer	0.00318	0.0162	CbGbCtD
Fluorouracil—ABCC3—Methotrexate—lung cancer	0.00318	0.0162	CbGbCtD
Fluorouracil—ABCG2—Erlotinib—lung cancer	0.00273	0.0139	CbGbCtD
Fluorouracil—ABCG2—Paclitaxel—lung cancer	0.0025	0.0127	CbGbCtD
Fluorouracil—SLC22A7—Methotrexate—lung cancer	0.00248	0.0126	CbGbCtD
Fluorouracil—ABCG2—Irinotecan—lung cancer	0.00247	0.0126	CbGbCtD
Fluorouracil—ABCC4—Methotrexate—lung cancer	0.00243	0.0124	CbGbCtD
Fluorouracil—ABCG2—Cisplatin—lung cancer	0.00201	0.0102	CbGbCtD
Fluorouracil—ABCG2—Etoposide—lung cancer	0.00197	0.0101	CbGbCtD
Fluorouracil—ALB—Erlotinib—lung cancer	0.00188	0.00958	CbGbCtD
Fluorouracil—ABCG2—Docetaxel—lung cancer	0.00181	0.0092	CbGbCtD
Fluorouracil—CYP2C9—Gefitinib—lung cancer	0.00172	0.00874	CbGbCtD
Fluorouracil—ALB—Irinotecan—lung cancer	0.0017	0.00865	CbGbCtD
Fluorouracil—CYP2C9—Teniposide—lung cancer	0.00166	0.00847	CbGbCtD
Fluorouracil—CYP2C8—Erlotinib—lung cancer	0.00145	0.00741	CbGbCtD
Fluorouracil—ABCG2—Doxorubicin—lung cancer	0.00135	0.00686	CbGbCtD
Fluorouracil—CYP2C8—Paclitaxel—lung cancer	0.00133	0.00678	CbGbCtD
Fluorouracil—ABCG2—Methotrexate—lung cancer	0.0013	0.00664	CbGbCtD
Fluorouracil—CYP1A2—Erlotinib—lung cancer	0.00113	0.00573	CbGbCtD
Fluorouracil—CYP2C8—Etoposide—lung cancer	0.00105	0.00536	CbGbCtD
Fluorouracil—CYP2C9—Paclitaxel—lung cancer	0.000929	0.00473	CbGbCtD
Fluorouracil—ALB—Methotrexate—lung cancer	0.000899	0.00458	CbGbCtD
Fluorouracil—DPYD—mammary gland—lung cancer	0.000848	0.0483	CbGeAlD
Fluorouracil—CYP1A2—Etoposide—lung cancer	0.000814	0.00415	CbGbCtD
Fluorouracil—CYP2C9—Cisplatin—lung cancer	0.000747	0.0038	CbGbCtD
Fluorouracil—UPP1—respiratory system—lung cancer	0.000696	0.0397	CbGeAlD
Fluorouracil—UMPS—bronchus—lung cancer	0.000625	0.0356	CbGeAlD
Fluorouracil—UPP1—bronchus—lung cancer	0.000573	0.0326	CbGeAlD
Fluorouracil—UPP1—trachea—lung cancer	0.000514	0.0293	CbGeAlD
Fluorouracil—TYMP—mammary gland—lung cancer	0.000492	0.028	CbGeAlD
Fluorouracil—UPP1—cardiac atrium—lung cancer	0.000483	0.0275	CbGeAlD
Fluorouracil—DPYD—bronchus—lung cancer	0.000465	0.0265	CbGeAlD
Fluorouracil—MTHFR—mammary gland—lung cancer	0.000462	0.0263	CbGeAlD
Fluorouracil—UMPS—bone marrow—lung cancer	0.000445	0.0254	CbGeAlD
Fluorouracil—ABCC5—mammary gland—lung cancer	0.000412	0.0235	CbGeAlD
Fluorouracil—UPP1—bone marrow—lung cancer	0.000408	0.0232	CbGeAlD
Fluorouracil—UMPS—lung—lung cancer	0.000403	0.023	CbGeAlD
Fluorouracil—DPYD—cardiac atrium—lung cancer	0.000392	0.0224	CbGeAlD
Fluorouracil—SLC29A1—mammary gland—lung cancer	0.000378	0.0215	CbGeAlD
Fluorouracil—UPP1—lung—lung cancer	0.00037	0.0211	CbGeAlD
Fluorouracil—DPYD—bone marrow—lung cancer	0.000331	0.0189	CbGeAlD
Fluorouracil—TYMP—respiratory system—lung cancer	0.000328	0.0187	CbGeAlD
Fluorouracil—MTHFR—respiratory system—lung cancer	0.000308	0.0175	CbGeAlD
Fluorouracil—DPYD—lung—lung cancer	0.0003	0.0171	CbGeAlD
Fluorouracil—ALB—mammary gland—lung cancer	0.000295	0.0168	CbGeAlD
Fluorouracil—PPAT—bone marrow—lung cancer	0.000287	0.0163	CbGeAlD
Fluorouracil—TYMS—respiratory system—lung cancer	0.000281	0.016	CbGeAlD
Fluorouracil—UMPS—lymph node—lung cancer	0.000276	0.0157	CbGeAlD
Fluorouracil—TYMP—bronchus—lung cancer	0.00027	0.0154	CbGeAlD
Fluorouracil—PPAT—lung—lung cancer	0.00026	0.0148	CbGeAlD
Fluorouracil—MTHFR—bronchus—lung cancer	0.000253	0.0144	CbGeAlD
Fluorouracil—UPP1—lymph node—lung cancer	0.000253	0.0144	CbGeAlD
Fluorouracil—SLC29A1—respiratory system—lung cancer	0.000252	0.0144	CbGeAlD
Fluorouracil—TYMP—trachea—lung cancer	0.000242	0.0138	CbGeAlD
Fluorouracil—TYMS—bronchus—lung cancer	0.000231	0.0132	CbGeAlD
Fluorouracil—ABCC3—respiratory system—lung cancer	0.00023	0.0131	CbGeAlD
Fluorouracil—TYMP—cardiac atrium—lung cancer	0.000227	0.013	CbGeAlD
Fluorouracil—UMPS—Afatinib—Gefitinib—lung cancer	0.000226	0.212	CbGdCrCtD
Fluorouracil—ABCC5—bronchus—lung cancer	0.000226	0.0129	CbGeAlD
Fluorouracil—SLC29A1—bronchus—lung cancer	0.000207	0.0118	CbGeAlD
Fluorouracil—CYP2C8—mammary gland—lung cancer	0.000207	0.0118	CbGeAlD
Fluorouracil—DPYD—lymph node—lung cancer	0.000205	0.0117	CbGeAlD
Fluorouracil—TYMP—bone marrow—lung cancer	0.000192	0.0109	CbGeAlD
Fluorouracil—ABCC5—cardiac atrium—lung cancer	0.000191	0.0109	CbGeAlD
Fluorouracil—SLC29A1—trachea—lung cancer	0.000186	0.0106	CbGeAlD
Fluorouracil—CYP2C9—mammary gland—lung cancer	0.000184	0.0105	CbGeAlD
Fluorouracil—PPAT—lymph node—lung cancer	0.000178	0.0101	CbGeAlD
Fluorouracil—SLC29A1—cardiac atrium—lung cancer	0.000175	0.00997	CbGeAlD
Fluorouracil—TYMP—lung—lung cancer	0.000174	0.00991	CbGeAlD
Fluorouracil—TYMS—bone marrow—lung cancer	0.000165	0.00938	CbGeAlD
Fluorouracil—MTHFR—lung—lung cancer	0.000164	0.00932	CbGeAlD
Fluorouracil—ABCC5—bone marrow—lung cancer	0.000161	0.00917	CbGeAlD
Fluorouracil—ABCC4—bronchus—lung cancer	0.000157	0.00892	CbGeAlD
Fluorouracil—TYMS—lung—lung cancer	0.000149	0.0085	CbGeAlD
Fluorouracil—SLC29A1—bone marrow—lung cancer	0.000148	0.00842	CbGeAlD
Fluorouracil—ABCC5—lung—lung cancer	0.000146	0.0083	CbGeAlD
Fluorouracil—SLC29A1—lung—lung cancer	0.000134	0.00762	CbGeAlD
Fluorouracil—CYP2A6—lung—lung cancer	0.000131	0.00744	CbGeAlD
Fluorouracil—CYP1A2—respiratory system—lung cancer	0.000129	0.00737	CbGeAlD
Fluorouracil—ABCC3—lung—lung cancer	0.000122	0.00697	CbGeAlD
Fluorouracil—TYMP—lymph node—lung cancer	0.000119	0.00678	CbGeAlD
Fluorouracil—TYMS—Docetaxel—Paclitaxel—lung cancer	0.000116	0.108	CbGdCrCtD
Fluorouracil—MTHFR—lymph node—lung cancer	0.000112	0.00637	CbGeAlD
Fluorouracil—ABCC4—bone marrow—lung cancer	0.000112	0.00635	CbGeAlD
Fluorouracil—TYMS—lymph node—lung cancer	0.000102	0.00582	CbGeAlD
Fluorouracil—ABCC4—lung—lung cancer	0.000101	0.00576	CbGeAlD
Fluorouracil—ABCC5—lymph node—lung cancer	9.97e-05	0.00568	CbGeAlD
Fluorouracil—SLC29A1—lymph node—lung cancer	9.15e-05	0.00521	CbGeAlD
Fluorouracil—TYMS—Erlotinib—Gefitinib—lung cancer	8.64e-05	0.081	CbGdCrCtD
Fluorouracil—ABCC3—lymph node—lung cancer	8.37e-05	0.00477	CbGeAlD
Fluorouracil—ABCG2—bone marrow—lung cancer	7.87e-05	0.00449	CbGeAlD
Fluorouracil—UMPS—Epirubicin—Doxorubicin—lung cancer	7.16e-05	0.067	CbGdCrCtD
Fluorouracil—UMPS—Daunorubicin—Doxorubicin—lung cancer	7.16e-05	0.067	CbGdCrCtD
Fluorouracil—UMPS—Idarubicin—Doxorubicin—lung cancer	7.16e-05	0.067	CbGdCrCtD
Fluorouracil—ALB—lymph node—lung cancer	7.14e-05	0.00407	CbGeAlD
Fluorouracil—ABCG2—lung—lung cancer	7.13e-05	0.00406	CbGeAlD
Fluorouracil—ABCC4—lymph node—lung cancer	6.91e-05	0.00394	CbGeAlD
Fluorouracil—CYP1A2—lung—lung cancer	6.86e-05	0.00391	CbGeAlD
Fluorouracil—TYMS—Podofilox—Teniposide—lung cancer	6.24e-05	0.0584	CbGdCrCtD
Fluorouracil—TYMS—Paclitaxel—Docetaxel—lung cancer	5.78e-05	0.0541	CbGdCrCtD
Fluorouracil—TYMS—Afatinib—Gefitinib—lung cancer	5.65e-05	0.0529	CbGdCrCtD
Fluorouracil—TYMS—Gefitinib—Erlotinib—lung cancer	5.54e-05	0.0519	CbGdCrCtD
Fluorouracil—ABCG2—lymph node—lung cancer	4.88e-05	0.00278	CbGeAlD
Fluorouracil—TYMS—Vincristine—Vinorelbine—lung cancer	3.97e-05	0.0372	CbGdCrCtD
Fluorouracil—TYMS—Vinorelbine—Vinblastine—lung cancer	3.71e-05	0.0348	CbGdCrCtD
Fluorouracil—TYMS—Podofilox—Etoposide—lung cancer	3.71e-05	0.0348	CbGdCrCtD
Fluorouracil—TYMS—Vinblastine—Vinorelbine—lung cancer	3.19e-05	0.0299	CbGdCrCtD
Fluorouracil—TYMS—Vincristine—Vinblastine—lung cancer	3.18e-05	0.0297	CbGdCrCtD
Fluorouracil—Nausea—Topotecan—lung cancer	2.01e-05	0.000413	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Gemcitabine—lung cancer	2e-05	0.000412	CcSEcCtD
Fluorouracil—Discomfort—Paclitaxel—lung cancer	2e-05	0.000412	CcSEcCtD
Fluorouracil—Confusional state—Etoposide—lung cancer	2e-05	0.000411	CcSEcCtD
Fluorouracil—Cardiac arrest—Doxorubicin—lung cancer	1.99e-05	0.000409	CcSEcCtD
Fluorouracil—Pain—Gemcitabine—lung cancer	1.98e-05	0.000408	CcSEcCtD
Fluorouracil—Nausea—Erlotinib—lung cancer	1.98e-05	0.000408	CcSEcCtD
Fluorouracil—Pancytopenia—Methotrexate—lung cancer	1.98e-05	0.000408	CcSEcCtD
Fluorouracil—Anaphylactic shock—Etoposide—lung cancer	1.98e-05	0.000408	CcSEcCtD
Fluorouracil—Diarrhoea—Vinorelbine—lung cancer	1.98e-05	0.000407	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Cisplatin—lung cancer	1.97e-05	0.000405	CcSEcCtD
Fluorouracil—Infection—Etoposide—lung cancer	1.97e-05	0.000405	CcSEcCtD
Fluorouracil—Ataxia—Doxorubicin—lung cancer	1.97e-05	0.000405	CcSEcCtD
Fluorouracil—Feeling abnormal—Irinotecan—lung cancer	1.96e-05	0.000404	CcSEcCtD
Fluorouracil—Confusional state—Paclitaxel—lung cancer	1.96e-05	0.000403	CcSEcCtD
Fluorouracil—Anaphylactic shock—Paclitaxel—lung cancer	1.94e-05	0.0004	CcSEcCtD
Fluorouracil—Oedema—Paclitaxel—lung cancer	1.94e-05	0.0004	CcSEcCtD
Fluorouracil—Paraesthesia—Cisplatin—lung cancer	1.94e-05	0.0004	CcSEcCtD
Fluorouracil—Thrombocytopenia—Etoposide—lung cancer	1.94e-05	0.000399	CcSEcCtD
Fluorouracil—Upper respiratory tract infection—Methotrexate—lung cancer	1.94e-05	0.000399	CcSEcCtD
Fluorouracil—Tachycardia—Etoposide—lung cancer	1.93e-05	0.000398	CcSEcCtD
Fluorouracil—Infection—Paclitaxel—lung cancer	1.93e-05	0.000397	CcSEcCtD
Fluorouracil—Dyspnoea—Cisplatin—lung cancer	1.93e-05	0.000397	CcSEcCtD
Fluorouracil—Dry skin—Doxorubicin—lung cancer	1.92e-05	0.000394	CcSEcCtD
Fluorouracil—Feeling abnormal—Gemcitabine—lung cancer	1.91e-05	0.000393	CcSEcCtD
Fluorouracil—Dizziness—Vinorelbine—lung cancer	1.91e-05	0.000393	CcSEcCtD
Fluorouracil—Nervous system disorder—Paclitaxel—lung cancer	1.9e-05	0.000392	CcSEcCtD
Fluorouracil—Photosensitivity reaction—Methotrexate—lung cancer	1.9e-05	0.000392	CcSEcCtD
Fluorouracil—Thrombocytopenia—Paclitaxel—lung cancer	1.9e-05	0.000391	CcSEcCtD
Fluorouracil—Tachycardia—Paclitaxel—lung cancer	1.9e-05	0.00039	CcSEcCtD
Fluorouracil—Anorexia—Etoposide—lung cancer	1.89e-05	0.000389	CcSEcCtD
Fluorouracil—Body temperature increased—Irinotecan—lung cancer	1.88e-05	0.000387	CcSEcCtD
Fluorouracil—Decreased appetite—Cisplatin—lung cancer	1.88e-05	0.000387	CcSEcCtD
Fluorouracil—Pneumonia—Methotrexate—lung cancer	1.87e-05	0.000385	CcSEcCtD
Fluorouracil—Nasopharyngitis—Doxorubicin—lung cancer	1.87e-05	0.000385	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Cisplatin—lung cancer	1.87e-05	0.000384	CcSEcCtD
Fluorouracil—Anaemia—Docetaxel—lung cancer	1.86e-05	0.000384	CcSEcCtD
Fluorouracil—Infestation NOS—Methotrexate—lung cancer	1.86e-05	0.000383	CcSEcCtD
Fluorouracil—Infestation—Methotrexate—lung cancer	1.86e-05	0.000383	CcSEcCtD
Fluorouracil—Anorexia—Paclitaxel—lung cancer	1.85e-05	0.000381	CcSEcCtD
Fluorouracil—Hypotension—Etoposide—lung cancer	1.85e-05	0.000381	CcSEcCtD
Fluorouracil—Pain—Cisplatin—lung cancer	1.85e-05	0.000381	CcSEcCtD
Fluorouracil—Muscular weakness—Doxorubicin—lung cancer	1.84e-05	0.000379	CcSEcCtD
Fluorouracil—Vomiting—Vinorelbine—lung cancer	1.84e-05	0.000378	CcSEcCtD
Fluorouracil—Body temperature increased—Gemcitabine—lung cancer	1.83e-05	0.000377	CcSEcCtD
Fluorouracil—Rash—Vinorelbine—lung cancer	1.82e-05	0.000375	CcSEcCtD
Fluorouracil—Dermatitis—Vinorelbine—lung cancer	1.82e-05	0.000374	CcSEcCtD
Fluorouracil—Hypotension—Paclitaxel—lung cancer	1.82e-05	0.000374	CcSEcCtD
Fluorouracil—Stomatitis—Methotrexate—lung cancer	1.81e-05	0.000373	CcSEcCtD
Fluorouracil—Headache—Vinorelbine—lung cancer	1.81e-05	0.000372	CcSEcCtD
Fluorouracil—Conjunctivitis—Methotrexate—lung cancer	1.81e-05	0.000372	CcSEcCtD
Fluorouracil—Dysphagia—Doxorubicin—lung cancer	1.81e-05	0.000372	CcSEcCtD
Fluorouracil—Leukopenia—Docetaxel—lung cancer	1.81e-05	0.000372	CcSEcCtD
Fluorouracil—Eosinophilia—Doxorubicin—lung cancer	1.79e-05	0.000368	CcSEcCtD
Fluorouracil—Feeling abnormal—Cisplatin—lung cancer	1.78e-05	0.000367	CcSEcCtD
Fluorouracil—Paraesthesia—Etoposide—lung cancer	1.78e-05	0.000366	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Paclitaxel—lung cancer	1.77e-05	0.000364	CcSEcCtD
Fluorouracil—Dyspnoea—Etoposide—lung cancer	1.77e-05	0.000363	CcSEcCtD
Fluorouracil—Somnolence—Etoposide—lung cancer	1.76e-05	0.000362	CcSEcCtD
Fluorouracil—Angina pectoris—Doxorubicin—lung cancer	1.76e-05	0.000362	CcSEcCtD
Fluorouracil—Insomnia—Paclitaxel—lung cancer	1.76e-05	0.000362	CcSEcCtD
Fluorouracil—Epistaxis—Methotrexate—lung cancer	1.75e-05	0.000361	CcSEcCtD
Fluorouracil—Hypersensitivity—Irinotecan—lung cancer	1.75e-05	0.000361	CcSEcCtD
Fluorouracil—Convulsion—Docetaxel—lung cancer	1.75e-05	0.00036	CcSEcCtD
Fluorouracil—Paraesthesia—Paclitaxel—lung cancer	1.74e-05	0.000359	CcSEcCtD
Fluorouracil—Agranulocytosis—Methotrexate—lung cancer	1.74e-05	0.000357	CcSEcCtD
Fluorouracil—Dyspnoea—Paclitaxel—lung cancer	1.73e-05	0.000356	CcSEcCtD
Fluorouracil—Somnolence—Paclitaxel—lung cancer	1.73e-05	0.000355	CcSEcCtD
Fluorouracil—Decreased appetite—Etoposide—lung cancer	1.72e-05	0.000354	CcSEcCtD
Fluorouracil—Chest pain—Docetaxel—lung cancer	1.72e-05	0.000353	CcSEcCtD
Fluorouracil—Myalgia—Docetaxel—lung cancer	1.72e-05	0.000353	CcSEcCtD
Fluorouracil—Pancytopenia—Doxorubicin—lung cancer	1.72e-05	0.000353	CcSEcCtD
Fluorouracil—Nausea—Vinorelbine—lung cancer	1.72e-05	0.000353	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Etoposide—lung cancer	1.71e-05	0.000352	CcSEcCtD
Fluorouracil—Dyspepsia—Paclitaxel—lung cancer	1.71e-05	0.000352	CcSEcCtD
Fluorouracil—Body temperature increased—Cisplatin—lung cancer	1.71e-05	0.000352	CcSEcCtD
Fluorouracil—Pain—Etoposide—lung cancer	1.69e-05	0.000349	CcSEcCtD
Fluorouracil—Decreased appetite—Paclitaxel—lung cancer	1.69e-05	0.000347	CcSEcCtD
Fluorouracil—Upper respiratory tract infection—Doxorubicin—lung cancer	1.68e-05	0.000346	CcSEcCtD
Fluorouracil—Haemoglobin—Methotrexate—lung cancer	1.68e-05	0.000345	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Paclitaxel—lung cancer	1.68e-05	0.000345	CcSEcCtD
Fluorouracil—Haemorrhage—Methotrexate—lung cancer	1.67e-05	0.000344	CcSEcCtD
Fluorouracil—Pain—Paclitaxel—lung cancer	1.66e-05	0.000342	CcSEcCtD
Fluorouracil—Confusional state—Docetaxel—lung cancer	1.66e-05	0.000342	CcSEcCtD
Fluorouracil—Pharyngitis—Methotrexate—lung cancer	1.66e-05	0.000341	CcSEcCtD
Fluorouracil—Photosensitivity reaction—Doxorubicin—lung cancer	1.65e-05	0.000339	CcSEcCtD
Fluorouracil—Anaphylactic shock—Docetaxel—lung cancer	1.65e-05	0.000339	CcSEcCtD
Fluorouracil—Oedema—Docetaxel—lung cancer	1.65e-05	0.000339	CcSEcCtD
Fluorouracil—Pruritus—Gemcitabine—lung cancer	1.64e-05	0.000338	CcSEcCtD
Fluorouracil—Infection—Docetaxel—lung cancer	1.64e-05	0.000337	CcSEcCtD
Fluorouracil—Feeling abnormal—Etoposide—lung cancer	1.63e-05	0.000336	CcSEcCtD
Fluorouracil—Diarrhoea—Irinotecan—lung cancer	1.63e-05	0.000335	CcSEcCtD
Fluorouracil—Pneumonia—Doxorubicin—lung cancer	1.62e-05	0.000333	CcSEcCtD
Fluorouracil—Nervous system disorder—Docetaxel—lung cancer	1.61e-05	0.000332	CcSEcCtD
Fluorouracil—Thrombocytopenia—Docetaxel—lung cancer	1.61e-05	0.000332	CcSEcCtD
Fluorouracil—Infestation NOS—Doxorubicin—lung cancer	1.61e-05	0.000332	CcSEcCtD
Fluorouracil—Infestation—Doxorubicin—lung cancer	1.61e-05	0.000332	CcSEcCtD
Fluorouracil—Tachycardia—Docetaxel—lung cancer	1.61e-05	0.000331	CcSEcCtD
Fluorouracil—Feeling abnormal—Paclitaxel—lung cancer	1.6e-05	0.000329	CcSEcCtD
Fluorouracil—Hypersensitivity—Cisplatin—lung cancer	1.59e-05	0.000328	CcSEcCtD
Fluorouracil—Diarrhoea—Gemcitabine—lung cancer	1.59e-05	0.000327	CcSEcCtD
Fluorouracil—Neuropathy peripheral—Doxorubicin—lung cancer	1.58e-05	0.000325	CcSEcCtD
Fluorouracil—Dizziness—Irinotecan—lung cancer	1.57e-05	0.000324	CcSEcCtD
Fluorouracil—Urticaria—Etoposide—lung cancer	1.57e-05	0.000324	CcSEcCtD
Fluorouracil—Stomatitis—Doxorubicin—lung cancer	1.57e-05	0.000323	CcSEcCtD
Fluorouracil—Anorexia—Docetaxel—lung cancer	1.57e-05	0.000323	CcSEcCtD
Fluorouracil—Body temperature increased—Etoposide—lung cancer	1.57e-05	0.000322	CcSEcCtD
Fluorouracil—Urinary tract infection—Doxorubicin—lung cancer	1.57e-05	0.000322	CcSEcCtD
Fluorouracil—Conjunctivitis—Doxorubicin—lung cancer	1.57e-05	0.000322	CcSEcCtD
Fluorouracil—Urticaria—Paclitaxel—lung cancer	1.54e-05	0.000318	CcSEcCtD
Fluorouracil—Hypotension—Docetaxel—lung cancer	1.54e-05	0.000317	CcSEcCtD
Fluorouracil—Body temperature increased—Paclitaxel—lung cancer	1.54e-05	0.000316	CcSEcCtD
Fluorouracil—Epistaxis—Doxorubicin—lung cancer	1.52e-05	0.000313	CcSEcCtD
Fluorouracil—Vomiting—Irinotecan—lung cancer	1.51e-05	0.000312	CcSEcCtD
Fluorouracil—Sinusitis—Doxorubicin—lung cancer	1.51e-05	0.000311	CcSEcCtD
Fluorouracil—Agranulocytosis—Doxorubicin—lung cancer	1.5e-05	0.000309	CcSEcCtD
Fluorouracil—Rash—Irinotecan—lung cancer	1.5e-05	0.000309	CcSEcCtD
Fluorouracil—Dermatitis—Irinotecan—lung cancer	1.5e-05	0.000309	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Docetaxel—lung cancer	1.5e-05	0.000309	CcSEcCtD
Fluorouracil—TYMS—Azacitidine—Gemcitabine—lung cancer	1.5e-05	0.014	CbGdCrCtD
Fluorouracil—Headache—Irinotecan—lung cancer	1.49e-05	0.000307	CcSEcCtD
Fluorouracil—Insomnia—Docetaxel—lung cancer	1.49e-05	0.000306	CcSEcCtD
Fluorouracil—Diarrhoea—Cisplatin—lung cancer	1.48e-05	0.000304	CcSEcCtD
Fluorouracil—Paraesthesia—Docetaxel—lung cancer	1.48e-05	0.000304	CcSEcCtD
Fluorouracil—Alopecia—Methotrexate—lung cancer	1.48e-05	0.000304	CcSEcCtD
Fluorouracil—Vomiting—Gemcitabine—lung cancer	1.48e-05	0.000304	CcSEcCtD
Fluorouracil—Dyspnoea—Docetaxel—lung cancer	1.47e-05	0.000302	CcSEcCtD
Fluorouracil—Somnolence—Docetaxel—lung cancer	1.46e-05	0.000301	CcSEcCtD
Fluorouracil—Rash—Gemcitabine—lung cancer	1.46e-05	0.000301	CcSEcCtD
Fluorouracil—Dermatitis—Gemcitabine—lung cancer	1.46e-05	0.000301	CcSEcCtD
Fluorouracil—Hypersensitivity—Etoposide—lung cancer	1.46e-05	0.0003	CcSEcCtD
Fluorouracil—Erythema—Methotrexate—lung cancer	1.45e-05	0.000299	CcSEcCtD
Fluorouracil—Haemoglobin—Doxorubicin—lung cancer	1.45e-05	0.000299	CcSEcCtD
Fluorouracil—Headache—Gemcitabine—lung cancer	1.45e-05	0.000299	CcSEcCtD
Fluorouracil—Rhinitis—Doxorubicin—lung cancer	1.45e-05	0.000298	CcSEcCtD
Fluorouracil—Dyspepsia—Docetaxel—lung cancer	1.45e-05	0.000298	CcSEcCtD
Fluorouracil—Haemorrhage—Doxorubicin—lung cancer	1.45e-05	0.000298	CcSEcCtD
Fluorouracil—Hypoaesthesia—Doxorubicin—lung cancer	1.44e-05	0.000296	CcSEcCtD
Fluorouracil—Pharyngitis—Doxorubicin—lung cancer	1.44e-05	0.000295	CcSEcCtD
Fluorouracil—Decreased appetite—Docetaxel—lung cancer	1.43e-05	0.000295	CcSEcCtD
Fluorouracil—Hypersensitivity—Paclitaxel—lung cancer	1.43e-05	0.000294	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Docetaxel—lung cancer	1.42e-05	0.000292	CcSEcCtD
Fluorouracil—Nausea—Irinotecan—lung cancer	1.41e-05	0.000291	CcSEcCtD
Fluorouracil—Pain—Docetaxel—lung cancer	1.41e-05	0.00029	CcSEcCtD
Fluorouracil—Pruritus—Etoposide—lung cancer	1.4e-05	0.000288	CcSEcCtD
Fluorouracil—Nausea—Gemcitabine—lung cancer	1.38e-05	0.000284	CcSEcCtD
Fluorouracil—Vomiting—Cisplatin—lung cancer	1.37e-05	0.000283	CcSEcCtD
Fluorouracil—Pruritus—Paclitaxel—lung cancer	1.37e-05	0.000283	CcSEcCtD
Fluorouracil—Vision blurred—Methotrexate—lung cancer	1.37e-05	0.000282	CcSEcCtD
Fluorouracil—Rash—Cisplatin—lung cancer	1.36e-05	0.000281	CcSEcCtD
Fluorouracil—Dermatitis—Cisplatin—lung cancer	1.36e-05	0.00028	CcSEcCtD
Fluorouracil—Feeling abnormal—Docetaxel—lung cancer	1.36e-05	0.000279	CcSEcCtD
Fluorouracil—Diarrhoea—Etoposide—lung cancer	1.36e-05	0.000279	CcSEcCtD
Fluorouracil—Anaemia—Methotrexate—lung cancer	1.34e-05	0.000277	CcSEcCtD
Fluorouracil—Diarrhoea—Paclitaxel—lung cancer	1.33e-05	0.000273	CcSEcCtD
Fluorouracil—Dizziness—Etoposide—lung cancer	1.31e-05	0.00027	CcSEcCtD
Fluorouracil—Body temperature increased—Docetaxel—lung cancer	1.3e-05	0.000268	CcSEcCtD
Fluorouracil—Leukopenia—Methotrexate—lung cancer	1.3e-05	0.000268	CcSEcCtD
Fluorouracil—Arrhythmia—Doxorubicin—lung cancer	1.29e-05	0.000266	CcSEcCtD
Fluorouracil—Dizziness—Paclitaxel—lung cancer	1.28e-05	0.000264	CcSEcCtD
Fluorouracil—Nausea—Cisplatin—lung cancer	1.28e-05	0.000264	CcSEcCtD
Fluorouracil—Alopecia—Doxorubicin—lung cancer	1.28e-05	0.000263	CcSEcCtD
Fluorouracil—Convulsion—Methotrexate—lung cancer	1.26e-05	0.000259	CcSEcCtD
Fluorouracil—Vomiting—Etoposide—lung cancer	1.26e-05	0.000259	CcSEcCtD
Fluorouracil—Erythema—Doxorubicin—lung cancer	1.26e-05	0.000259	CcSEcCtD
Fluorouracil—Rash—Etoposide—lung cancer	1.25e-05	0.000257	CcSEcCtD
Fluorouracil—Dermatitis—Etoposide—lung cancer	1.25e-05	0.000257	CcSEcCtD
Fluorouracil—Headache—Etoposide—lung cancer	1.24e-05	0.000255	CcSEcCtD
Fluorouracil—Myalgia—Methotrexate—lung cancer	1.24e-05	0.000255	CcSEcCtD
Fluorouracil—Chest pain—Methotrexate—lung cancer	1.24e-05	0.000255	CcSEcCtD
Fluorouracil—Vomiting—Paclitaxel—lung cancer	1.24e-05	0.000254	CcSEcCtD
Fluorouracil—Rash—Paclitaxel—lung cancer	1.22e-05	0.000252	CcSEcCtD
Fluorouracil—Dermatitis—Paclitaxel—lung cancer	1.22e-05	0.000252	CcSEcCtD
Fluorouracil—Discomfort—Methotrexate—lung cancer	1.22e-05	0.000252	CcSEcCtD
Fluorouracil—Headache—Paclitaxel—lung cancer	1.22e-05	0.00025	CcSEcCtD
Fluorouracil—Hypersensitivity—Docetaxel—lung cancer	1.21e-05	0.00025	CcSEcCtD
Fluorouracil—Confusional state—Methotrexate—lung cancer	1.2e-05	0.000246	CcSEcCtD
Fluorouracil—Anaphylactic shock—Methotrexate—lung cancer	1.19e-05	0.000244	CcSEcCtD
Fluorouracil—Vision blurred—Doxorubicin—lung cancer	1.19e-05	0.000244	CcSEcCtD
Fluorouracil—Infection—Methotrexate—lung cancer	1.18e-05	0.000243	CcSEcCtD
Fluorouracil—Nausea—Etoposide—lung cancer	1.18e-05	0.000242	CcSEcCtD
Fluorouracil—Pruritus—Docetaxel—lung cancer	1.16e-05	0.00024	CcSEcCtD
Fluorouracil—Nervous system disorder—Methotrexate—lung cancer	1.16e-05	0.000239	CcSEcCtD
Fluorouracil—Anaemia—Doxorubicin—lung cancer	1.16e-05	0.000239	CcSEcCtD
Fluorouracil—Thrombocytopenia—Methotrexate—lung cancer	1.16e-05	0.000239	CcSEcCtD
Fluorouracil—Nausea—Paclitaxel—lung cancer	1.15e-05	0.000237	CcSEcCtD
Fluorouracil—Anorexia—Methotrexate—lung cancer	1.13e-05	0.000233	CcSEcCtD
Fluorouracil—Leukopenia—Doxorubicin—lung cancer	1.13e-05	0.000232	CcSEcCtD
Fluorouracil—Diarrhoea—Docetaxel—lung cancer	1.13e-05	0.000232	CcSEcCtD
Fluorouracil—Hypotension—Methotrexate—lung cancer	1.11e-05	0.000228	CcSEcCtD
Fluorouracil—Convulsion—Doxorubicin—lung cancer	1.09e-05	0.000224	CcSEcCtD
Fluorouracil—Dizziness—Docetaxel—lung cancer	1.09e-05	0.000224	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Methotrexate—lung cancer	1.08e-05	0.000222	CcSEcCtD
Fluorouracil—Insomnia—Methotrexate—lung cancer	1.07e-05	0.000221	CcSEcCtD
Fluorouracil—Myalgia—Doxorubicin—lung cancer	1.07e-05	0.000221	CcSEcCtD
Fluorouracil—Chest pain—Doxorubicin—lung cancer	1.07e-05	0.000221	CcSEcCtD
Fluorouracil—Paraesthesia—Methotrexate—lung cancer	1.07e-05	0.000219	CcSEcCtD
Fluorouracil—Discomfort—Doxorubicin—lung cancer	1.06e-05	0.000218	CcSEcCtD
Fluorouracil—Dyspnoea—Methotrexate—lung cancer	1.06e-05	0.000218	CcSEcCtD
Fluorouracil—Somnolence—Methotrexate—lung cancer	1.05e-05	0.000217	CcSEcCtD
Fluorouracil—Vomiting—Docetaxel—lung cancer	1.05e-05	0.000215	CcSEcCtD
Fluorouracil—Dyspepsia—Methotrexate—lung cancer	1.04e-05	0.000215	CcSEcCtD
Fluorouracil—Rash—Docetaxel—lung cancer	1.04e-05	0.000214	CcSEcCtD
Fluorouracil—Dermatitis—Docetaxel—lung cancer	1.04e-05	0.000213	CcSEcCtD
Fluorouracil—Confusional state—Doxorubicin—lung cancer	1.04e-05	0.000213	CcSEcCtD
Fluorouracil—Decreased appetite—Methotrexate—lung cancer	1.03e-05	0.000212	CcSEcCtD
Fluorouracil—Headache—Docetaxel—lung cancer	1.03e-05	0.000212	CcSEcCtD
Fluorouracil—Oedema—Doxorubicin—lung cancer	1.03e-05	0.000211	CcSEcCtD
Fluorouracil—Anaphylactic shock—Doxorubicin—lung cancer	1.03e-05	0.000211	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Methotrexate—lung cancer	1.02e-05	0.000211	CcSEcCtD
Fluorouracil—Infection—Doxorubicin—lung cancer	1.02e-05	0.00021	CcSEcCtD
Fluorouracil—Pain—Methotrexate—lung cancer	1.01e-05	0.000209	CcSEcCtD
Fluorouracil—Nervous system disorder—Doxorubicin—lung cancer	1.01e-05	0.000207	CcSEcCtD
Fluorouracil—Thrombocytopenia—Doxorubicin—lung cancer	1.01e-05	0.000207	CcSEcCtD
Fluorouracil—Tachycardia—Doxorubicin—lung cancer	1e-05	0.000206	CcSEcCtD
Fluorouracil—Anorexia—Doxorubicin—lung cancer	9.79e-06	0.000202	CcSEcCtD
Fluorouracil—Nausea—Docetaxel—lung cancer	9.78e-06	0.000201	CcSEcCtD
Fluorouracil—Feeling abnormal—Methotrexate—lung cancer	9.78e-06	0.000201	CcSEcCtD
Fluorouracil—Hypotension—Doxorubicin—lung cancer	9.6e-06	0.000198	CcSEcCtD
Fluorouracil—Urticaria—Methotrexate—lung cancer	9.43e-06	0.000194	CcSEcCtD
Fluorouracil—Body temperature increased—Methotrexate—lung cancer	9.38e-06	0.000193	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Doxorubicin—lung cancer	9.36e-06	0.000193	CcSEcCtD
Fluorouracil—Insomnia—Doxorubicin—lung cancer	9.29e-06	0.000191	CcSEcCtD
Fluorouracil—Paraesthesia—Doxorubicin—lung cancer	9.23e-06	0.00019	CcSEcCtD
Fluorouracil—Dyspnoea—Doxorubicin—lung cancer	9.16e-06	0.000189	CcSEcCtD
Fluorouracil—Somnolence—Doxorubicin—lung cancer	9.13e-06	0.000188	CcSEcCtD
Fluorouracil—Dyspepsia—Doxorubicin—lung cancer	9.04e-06	0.000186	CcSEcCtD
Fluorouracil—Decreased appetite—Doxorubicin—lung cancer	8.93e-06	0.000184	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Doxorubicin—lung cancer	8.87e-06	0.000183	CcSEcCtD
Fluorouracil—Pain—Doxorubicin—lung cancer	8.79e-06	0.000181	CcSEcCtD
Fluorouracil—Hypersensitivity—Methotrexate—lung cancer	8.74e-06	0.00018	CcSEcCtD
Fluorouracil—Feeling abnormal—Doxorubicin—lung cancer	8.47e-06	0.000174	CcSEcCtD
Fluorouracil—Pruritus—Methotrexate—lung cancer	8.4e-06	0.000173	CcSEcCtD
Fluorouracil—Urticaria—Doxorubicin—lung cancer	8.16e-06	0.000168	CcSEcCtD
Fluorouracil—Body temperature increased—Doxorubicin—lung cancer	8.12e-06	0.000167	CcSEcCtD
Fluorouracil—Diarrhoea—Methotrexate—lung cancer	8.12e-06	0.000167	CcSEcCtD
Fluorouracil—Dizziness—Methotrexate—lung cancer	7.85e-06	0.000161	CcSEcCtD
Fluorouracil—Hypersensitivity—Doxorubicin—lung cancer	7.57e-06	0.000156	CcSEcCtD
Fluorouracil—Vomiting—Methotrexate—lung cancer	7.54e-06	0.000155	CcSEcCtD
Fluorouracil—Rash—Methotrexate—lung cancer	7.48e-06	0.000154	CcSEcCtD
Fluorouracil—Dermatitis—Methotrexate—lung cancer	7.47e-06	0.000154	CcSEcCtD
Fluorouracil—Headache—Methotrexate—lung cancer	7.43e-06	0.000153	CcSEcCtD
Fluorouracil—Pruritus—Doxorubicin—lung cancer	7.27e-06	0.00015	CcSEcCtD
Fluorouracil—Nausea—Methotrexate—lung cancer	7.05e-06	0.000145	CcSEcCtD
Fluorouracil—Diarrhoea—Doxorubicin—lung cancer	7.03e-06	0.000145	CcSEcCtD
Fluorouracil—Dizziness—Doxorubicin—lung cancer	6.79e-06	0.00014	CcSEcCtD
Fluorouracil—Vomiting—Doxorubicin—lung cancer	6.53e-06	0.000134	CcSEcCtD
Fluorouracil—Rash—Doxorubicin—lung cancer	6.48e-06	0.000133	CcSEcCtD
Fluorouracil—Dermatitis—Doxorubicin—lung cancer	6.47e-06	0.000133	CcSEcCtD
Fluorouracil—Headache—Doxorubicin—lung cancer	6.44e-06	0.000132	CcSEcCtD
Fluorouracil—Nausea—Doxorubicin—lung cancer	6.1e-06	0.000126	CcSEcCtD
Fluorouracil—CYP2C9—Metabolism—AKR1C1—lung cancer	1.17e-06	2.96e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—GSTP1—lung cancer	1.17e-06	2.95e-05	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—PTGS2—lung cancer	1.17e-06	2.95e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—MAPK3—lung cancer	1.17e-06	2.95e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.16e-06	2.94e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.16e-06	2.92e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—GSTT1—lung cancer	1.15e-06	2.91e-05	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—AKT1—lung cancer	1.15e-06	2.9e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—GSTT1—lung cancer	1.15e-06	2.89e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—PTEN—lung cancer	1.14e-06	2.89e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—B4GALT5—lung cancer	1.14e-06	2.89e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CYP2A6—lung cancer	1.14e-06	2.88e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—GCLC—lung cancer	1.14e-06	2.88e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—CAT—lung cancer	1.14e-06	2.87e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—UGT1A1—lung cancer	1.14e-06	2.87e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—MYC—lung cancer	1.14e-06	2.87e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.13e-06	2.87e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—GCLC—lung cancer	1.13e-06	2.86e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CYP2A6—lung cancer	1.13e-06	2.86e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.13e-06	2.85e-05	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—AKT1—lung cancer	1.13e-06	2.85e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—CYP1A1—lung cancer	1.12e-06	2.83e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PIK3CD—lung cancer	1.12e-06	2.83e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—ERCC2—lung cancer	1.11e-06	2.81e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—GSTA4—lung cancer	1.11e-06	2.81e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—EGFR—lung cancer	1.11e-06	2.8e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—PIK3CA—lung cancer	1.11e-06	2.8e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—ABCB1—lung cancer	1.11e-06	2.8e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—ALB—lung cancer	1.11e-06	2.79e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—GNG11—lung cancer	1.1e-06	2.77e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—EP300—lung cancer	1.09e-06	2.76e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.09e-06	2.76e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—TYMS—lung cancer	1.09e-06	2.75e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	1.09e-06	2.74e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—GSTA2—lung cancer	1.08e-06	2.74e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—ENO1—lung cancer	1.08e-06	2.73e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.08e-06	2.72e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—GSTM1—lung cancer	1.07e-06	2.71e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—ENO1—lung cancer	1.07e-06	2.71e-05	CbGpPWpGaD
Fluorouracil—ALB—Transmembrane transport of small molecules—CREBBP—lung cancer	1.07e-06	2.71e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.07e-06	2.7e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.06e-06	2.68e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—RAF1—lung cancer	1.05e-06	2.65e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—KRAS—lung cancer	1.05e-06	2.65e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—GSTA1—lung cancer	1.05e-06	2.64e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ALDOA—lung cancer	1.04e-06	2.64e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ABCC3—lung cancer	1.03e-06	2.61e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—PIK3CB—lung cancer	1.02e-06	2.59e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—HRAS—lung cancer	1.02e-06	2.59e-05	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—PTEN—lung cancer	1.02e-06	2.57e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—CYP1A1—lung cancer	1.02e-06	2.57e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—NCOA3—lung cancer	1.01e-06	2.56e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—ERCC2—lung cancer	1.01e-06	2.55e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—AKR1C1—lung cancer	1e-06	2.53e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	9.96e-07	2.52e-05	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—AKT1—lung cancer	9.89e-07	2.5e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ADCY1—lung cancer	9.86e-07	2.49e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ABCG2—lung cancer	9.86e-07	2.49e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—IL6—lung cancer	9.8e-07	2.48e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PIK3CB—lung cancer	9.76e-07	2.46e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—UGT1A1—lung cancer	9.72e-07	2.45e-05	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—EP300—lung cancer	9.72e-07	2.45e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CYP2E1—lung cancer	9.68e-07	2.45e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PTGS2—lung cancer	9.67e-07	2.44e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ENO2—lung cancer	9.67e-07	2.44e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—HPGDS—lung cancer	9.67e-07	2.44e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—PIK3CA—lung cancer	9.64e-07	2.43e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CYP2E1—lung cancer	9.63e-07	2.43e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—APOA1—lung cancer	9.62e-07	2.43e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PPP2R1B—lung cancer	9.61e-07	2.43e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—NQO1—lung cancer	9.58e-07	2.42e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—NQO1—lung cancer	9.52e-07	2.4e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	9.48e-07	2.39e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—IL2—lung cancer	9.41e-07	2.38e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—GSTT1—lung cancer	9.38e-07	2.37e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	9.38e-07	2.37e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—GNG11—lung cancer	9.37e-07	2.37e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	9.32e-07	2.35e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	9.32e-07	2.35e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	9.29e-07	2.35e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—PIK3CA—lung cancer	9.27e-07	2.34e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CYP2A6—lung cancer	9.27e-07	2.34e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—GCLC—lung cancer	9.27e-07	2.34e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	9.24e-07	2.33e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	9.23e-07	2.33e-05	CbGpPWpGaD
Fluorouracil—ALB—Transmembrane transport of small molecules—RAF1—lung cancer	9.08e-07	2.29e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—AKT1—lung cancer	9.04e-07	2.28e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ALDOA—lung cancer	8.92e-07	2.25e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—HRAS—lung cancer	8.92e-07	2.25e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ENO1—lung cancer	8.79e-07	2.22e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PIK3CG—lung cancer	8.78e-07	2.22e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	8.76e-07	2.21e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—APOA1—lung cancer	8.74e-07	2.21e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—NCOA3—lung cancer	8.66e-07	2.19e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	8.64e-07	2.18e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—STK11—lung cancer	8.63e-07	2.18e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—STK11—lung cancer	8.58e-07	2.17e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—IL6—lung cancer	8.53e-07	2.15e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	8.51e-07	2.15e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—EP300—lung cancer	8.44e-07	2.13e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PTEN—lung cancer	8.43e-07	2.13e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ADCY1—lung cancer	8.43e-07	2.13e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ABCG2—lung cancer	8.43e-07	2.13e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—POMC—lung cancer	8.36e-07	2.11e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—HPGDS—lung cancer	8.26e-07	2.09e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ENO2—lung cancer	8.26e-07	2.09e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PPP2R1B—lung cancer	8.21e-07	2.07e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—SRC—lung cancer	8.21e-07	2.07e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—CREBBP—lung cancer	8.14e-07	2.06e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—lung cancer	8.1e-07	2.05e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	8.1e-07	2.05e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—PIK3CA—lung cancer	8.07e-07	2.04e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PTEN—lung cancer	8.06e-07	2.03e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—EP300—lung cancer	8.04e-07	2.03e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—GSTT1—lung cancer	8.01e-07	2.02e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—VEGFA—lung cancer	7.99e-07	2.02e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—GSTP1—lung cancer	7.99e-07	2.02e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PIK3CG—lung cancer	7.98e-07	2.01e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—GSTP1—lung cancer	7.94e-07	2.01e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—GCLC—lung cancer	7.92e-07	2e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CYP2A6—lung cancer	7.92e-07	2e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—NRAS—lung cancer	7.9e-07	1.99e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	7.89e-07	1.99e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CYP2E1—lung cancer	7.88e-07	1.99e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—AKT1—lung cancer	7.87e-07	1.99e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—NQO1—lung cancer	7.79e-07	1.97e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CAT—lung cancer	7.77e-07	1.96e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CAT—lung cancer	7.73e-07	1.95e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—EP300—lung cancer	7.73e-07	1.95e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PIK3CD—lung cancer	7.72e-07	1.95e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—EP300—lung cancer	7.68e-07	1.94e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	7.63e-07	1.93e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—ALB—lung cancer	7.62e-07	1.92e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—POMC—lung cancer	7.59e-07	1.92e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—AKT1—lung cancer	7.57e-07	1.91e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	7.56e-07	1.91e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—MAPK3—lung cancer	7.56e-07	1.91e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—ABCB1—lung cancer	7.56e-07	1.91e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—ABCB1—lung cancer	7.52e-07	1.9e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ENO1—lung cancer	7.51e-07	1.9e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	7.48e-07	1.89e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—TYMS—lung cancer	7.43e-07	1.88e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—CREBBP—lung cancer	7.4e-07	1.87e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	7.39e-07	1.87e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—TYMS—lung cancer	7.38e-07	1.86e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—GSTM1—lung cancer	7.34e-07	1.85e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—GSTM1—lung cancer	7.3e-07	1.84e-05	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—PIK3CA—lung cancer	7.19e-07	1.82e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—STK11—lung cancer	7.03e-07	1.77e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PIK3CD—lung cancer	7.01e-07	1.77e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CYP1A1—lung cancer	6.96e-07	1.76e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—ALB—lung cancer	6.92e-07	1.75e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CYP1A1—lung cancer	6.92e-07	1.75e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—ERCC2—lung cancer	6.9e-07	1.74e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—ERCC2—lung cancer	6.86e-07	1.73e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—KRAS—lung cancer	6.8e-07	1.72e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CYP2E1—lung cancer	6.74e-07	1.7e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PIK3CB—lung cancer	6.73e-07	1.7e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PTGS2—lung cancer	6.67e-07	1.68e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—NQO1—lung cancer	6.66e-07	1.68e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	6.59e-07	1.67e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—AKT1—lung cancer	6.59e-07	1.66e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	6.52e-07	1.65e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—GSTP1—lung cancer	6.5e-07	1.64e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	6.46e-07	1.63e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CAT—lung cancer	6.33e-07	1.6e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	6.29e-07	1.59e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—PIK3CA—lung cancer	6.24e-07	1.58e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ABCB1—lung cancer	6.15e-07	1.55e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PIK3CB—lung cancer	6.11e-07	1.54e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PTGS2—lung cancer	6.06e-07	1.53e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—TYMS—lung cancer	6.04e-07	1.53e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—TP53—lung cancer	6.04e-07	1.53e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—STK11—lung cancer	6e-07	1.52e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—GSTM1—lung cancer	5.97e-07	1.51e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—APOA1—lung cancer	5.97e-07	1.51e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PIK3CA—lung cancer	5.95e-07	1.5e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—APOA1—lung cancer	5.94e-07	1.5e-05	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—AKT1—lung cancer	5.87e-07	1.48e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PTEN—lung cancer	5.81e-07	1.47e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—HRAS—lung cancer	5.78e-07	1.46e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	5.72e-07	1.44e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	5.68e-07	1.44e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CYP1A1—lung cancer	5.66e-07	1.43e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	5.64e-07	1.42e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ERCC2—lung cancer	5.62e-07	1.42e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—GSTP1—lung cancer	5.55e-07	1.4e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—EP300—lung cancer	5.55e-07	1.4e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PIK3CG—lung cancer	5.45e-07	1.38e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PIK3CG—lung cancer	5.42e-07	1.37e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CAT—lung cancer	5.41e-07	1.37e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	5.37e-07	1.36e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PTEN—lung cancer	5.28e-07	1.33e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ABCB1—lung cancer	5.26e-07	1.33e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—POMC—lung cancer	5.19e-07	1.31e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—TYMS—lung cancer	5.16e-07	1.3e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—POMC—lung cancer	5.16e-07	1.3e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—GSTM1—lung cancer	5.1e-07	1.29e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—AKT1—lung cancer	5.1e-07	1.29e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CREBBP—lung cancer	5.05e-07	1.28e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—EP300—lung cancer	5.04e-07	1.27e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CREBBP—lung cancer	5.02e-07	1.27e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—AKT1—lung cancer	4.86e-07	1.23e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—APOA1—lung cancer	4.86e-07	1.23e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CYP1A1—lung cancer	4.84e-07	1.22e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ERCC2—lung cancer	4.8e-07	1.21e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PIK3CD—lung cancer	4.79e-07	1.21e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PIK3CD—lung cancer	4.76e-07	1.2e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—ALB—lung cancer	4.73e-07	1.19e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	4.65e-07	1.17e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PIK3CG—lung cancer	4.44e-07	1.12e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—POMC—lung cancer	4.22e-07	1.07e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PIK3CB—lung cancer	4.18e-07	1.05e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PIK3CB—lung cancer	4.15e-07	1.05e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—APOA1—lung cancer	4.15e-07	1.05e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PTGS2—lung cancer	4.14e-07	1.04e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PTGS2—lung cancer	4.11e-07	1.04e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CREBBP—lung cancer	4.11e-07	1.04e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PIK3CA—lung cancer	4.1e-07	1.04e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.98e-07	1e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PIK3CD—lung cancer	3.9e-07	9.85e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ALB—lung cancer	3.85e-07	9.72e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PIK3CG—lung cancer	3.79e-07	9.57e-06	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PIK3CA—lung cancer	3.73e-07	9.41e-06	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PTEN—lung cancer	3.61e-07	9.11e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—POMC—lung cancer	3.61e-07	9.11e-06	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PTEN—lung cancer	3.59e-07	9.06e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CREBBP—lung cancer	3.51e-07	8.87e-06	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—EP300—lung cancer	3.44e-07	8.69e-06	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—EP300—lung cancer	3.42e-07	8.64e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PIK3CB—lung cancer	3.4e-07	8.58e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PTGS2—lung cancer	3.37e-07	8.5e-06	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—AKT1—lung cancer	3.35e-07	8.46e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PIK3CD—lung cancer	3.33e-07	8.41e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ALB—lung cancer	3.29e-07	8.31e-06	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—AKT1—lung cancer	3.04e-07	7.69e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PTEN—lung cancer	2.94e-07	7.42e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PIK3CB—lung cancer	2.9e-07	7.33e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PTGS2—lung cancer	2.88e-07	7.27e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—EP300—lung cancer	2.8e-07	7.07e-06	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PIK3CA—lung cancer	2.55e-07	6.43e-06	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PIK3CA—lung cancer	2.53e-07	6.39e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PTEN—lung cancer	2.51e-07	6.34e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—EP300—lung cancer	2.39e-07	6.04e-06	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—AKT1—lung cancer	2.08e-07	5.25e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PIK3CA—lung cancer	2.07e-07	5.23e-06	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—AKT1—lung cancer	2.07e-07	5.22e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PIK3CA—lung cancer	1.77e-07	4.47e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—AKT1—lung cancer	1.69e-07	4.27e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—AKT1—lung cancer	1.45e-07	3.65e-06	CbGpPWpGaD
